NYSE:CLX

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

The Clorox Company manufactures and markets consumer and professional products worldwide. More Details


Snowflake Analysis

Established dividend payer with adequate balance sheet.


Similar Companies

Share Price & News

How has Clorox's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: CLX has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

-4.3%

CLX

-1.0%

US Household Products

0.08%

US Market


1 Year Return

38.6%

CLX

13.2%

US Household Products

12.8%

US Market

Return vs Industry: CLX exceeded the US Household Products industry which returned 13.2% over the past year.

Return vs Market: CLX exceeded the US Market which returned 12.8% over the past year.


Shareholder returns

CLXIndustryMarket
7 Day-4.3%-1.0%0.08%
30 Day-8.0%-1.6%-1.8%
90 Day-2.5%12.6%7.2%
1 Year41.9%38.6%16.0%13.2%15.3%12.8%
3 Year72.4%59.5%53.2%41.1%39.2%29.9%
5 Year107.0%82.3%99.3%73.5%88.3%67.1%

Price Volatility Vs. Market

How volatile is Clorox's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Clorox undervalued compared to its fair value and its price relative to the market?

27.89x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: CLX ($208.15) is trading above our estimate of fair value ($172.27)

Significantly Below Fair Value: CLX is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: CLX is poor value based on its PE Ratio (27.9x) compared to the US Household Products industry average (24.3x).

PE vs Market: CLX is poor value based on its PE Ratio (27.9x) compared to the US market (18.2x).


Price to Earnings Growth Ratio

PEG Ratio: CLX is poor value based on its PEG Ratio (9.1x)


Price to Book Ratio

PB vs Industry: CLX is overvalued based on its PB Ratio (28.9x) compared to the US Household Products industry average (7.1x).


Next Steps

Future Growth

How is Clorox forecast to perform in the next 1 to 3 years based on estimates from 12 analysts?

3.1%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: CLX's forecast earnings growth (3.1% per year) is above the savings rate (2.2%).

Earnings vs Market: CLX's earnings (3.1% per year) are forecast to grow slower than the US market (23.1% per year).

High Growth Earnings: CLX's earnings are forecast to grow, but not significantly.

Revenue vs Market: CLX's revenue (3.1% per year) is forecast to grow slower than the US market (9.8% per year).

High Growth Revenue: CLX's revenue (3.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: CLX's Return on Equity is forecast to be very high in 3 years time (118.4%).


Next Steps

Past Performance

How has Clorox performed over the past 5 years?

7.5%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: CLX has high quality earnings.

Growing Profit Margin: CLX's current net profit margins (14%) are higher than last year (13.2%).


Past Earnings Growth Analysis

Earnings Trend: CLX's earnings have grown by 7.5% per year over the past 5 years.

Accelerating Growth: CLX's earnings growth over the past year (14.5%) exceeds its 5-year average (7.5% per year).

Earnings vs Industry: CLX earnings growth over the past year (14.5%) underperformed the Household Products industry 30.9%.


Return on Equity

High ROE: Whilst CLX's Return on Equity (103.41%) is outstanding, this metric is skewed due to their high level of debt.


Next Steps

Financial Health

How is Clorox's financial position?


Financial Position Analysis

Short Term Liabilities: CLX's short term assets ($2.0B) exceed its short term liabilities ($1.4B).

Long Term Liabilities: CLX's short term assets ($2.0B) do not cover its long term liabilities ($3.9B).


Debt to Equity History and Analysis

Debt Level: CLX's debt to equity ratio (306.2%) is considered high.

Reducing Debt: CLX's debt to equity ratio has reduced from 1857.1% to 306.2% over the past 5 years.

Debt Coverage: CLX's debt is well covered by operating cash flow (55.6%).

Interest Coverage: CLX's interest payments on its debt are well covered by EBIT (12.9x coverage).


Balance Sheet


Next Steps

Dividend

What is Clorox current dividend yield, its reliability and sustainability?

2.13%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: CLX's dividend (2.13%) is higher than the bottom 25% of dividend payers in the US market (1.66%).

High Dividend: CLX's dividend (2.13%) is low compared to the top 25% of dividend payers in the US market (4.7%).


Stability and Growth of Payments

Stable Dividend: CLX's dividends per share have been stable in the past 10 years.

Growing Dividend: CLX's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonable payout ratio (57.5%), CLX's dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: CLX's dividends in 3 years are forecast to be covered by earnings (58.4% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.1yrs

Average management tenure


CEO

Linda Rendle (42 yo)

no data

Tenure

US$2,160,868

Compensation

Ms. Linda Rendle serves as Chief Executive Officer of The Clorox Company since September 14 2020 and serves as its Director since 2020. She served as President of The Clorox Company from May 4, 2020 to Sep ...


CEO Compensation Analysis

Compensation vs Market: Linda's total compensation ($USD2.16M) is below average for companies of similar size in the US market ($USD11.35M).

Compensation vs Earnings: Linda's compensation has increased by more than 20% in the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Benno Dorer
Executive Chairman4.08yrsUS$9.36m0.093%
$ 24.5m
Linda Rendle
CEO & Directorno dataUS$2.16m0.0087%
$ 2.3m
Kevin Jacobsen
Executive VP & CFO2.42yrsUS$2.29m0.0088%
$ 2.3m
Eric Reynolds
Executive VP & COOno dataUS$1.72m0.0085%
$ 2.2m
Laura Stein
Executive VP of Corporate Affairs & General Counsel15.67yrsUS$2.97m0.053%
$ 13.9m
Jeff Baker
VP, Chief Accounting Officer & Corporate Controller3.67yrsno data0.0034%
$ 880.1k
Chau Banks
Senior VP and Chief Information & Enterprise Analytics Officer0.25yrno datano data
Lisah Burhan
Vice President of Investor Relationsno datano datano data
William Bailey
Senior Vice President of Corporate & Business Development4.67yrsno data0.0068%
$ 1.8m
Stacey Grier
Senior VP and Chief Marketing & Strategy Officer1.67yrsno data0.00079%
$ 207.5k
Kirsten Marriner
Executive VP & Chief People Officer4.5yrsno data0.0054%
$ 1.4m
Erbie Foster
Chief Diversity Officer14.25yrsno datano data

4.1yrs

Average Tenure

52.5yo

Average Age

Experienced Management: CLX's management team is considered experienced (4.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Benno Dorer
Executive Chairman4.08yrsUS$9.36m0.093%
$ 24.5m
Linda Rendle
CEO & Directorno dataUS$2.16m0.0087%
$ 2.3m
Spencer Fleischer
Independent Director5.17yrsUS$265.11k0.00025%
$ 65.7k
Allan MacKay
Independent Director4.08yrsUS$252.50k0.0013%
$ 333.6k
Robert Matschullat
Independent Director21.67yrsUS$252.50k0.0010%
$ 275.8k
Christopher Williams
Independent Director5.17yrsUS$252.50kno data
Pamela Thomas-Graham
Lead Independent Director4.08yrsUS$302.50k0.0014%
$ 370.4k
Amy Banse
Independent Director4yrsUS$252.50kno data
Esther Lee
Independent Director7.08yrsUS$252.50kno data
Matthew Shattock
Independent Director2.08yrsUS$205.68kno data
Richard Carmona
Independent Director13.58yrsUS$267.50kno data
Russell Weiner
Independent Director3.58yrsUS$252.50kno data

4.1yrs

Average Tenure

61.5yo

Average Age

Experienced Board: CLX's board of directors are considered experienced (4.1 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: CLX insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

The Clorox Company's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: The Clorox Company
  • Ticker: CLX
  • Exchange: NYSE
  • Founded: 1913
  • Industry: Household Products
  • Sector: Household
  • Market Cap: US$26.271b
  • Shares outstanding: 126.21m
  • Website: https://www.thecloroxcompany.com

Number of Employees


Location

  • The Clorox Company
  • 1221 Broadway
  • Oakland
  • California
  • 94612-1888
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CLXNYSE (New York Stock Exchange)YesCommon StockUSUSDAug 1968
CXXDB (Deutsche Boerse AG)YesCommon StockDEEURAug 1968
0I0JLSE (London Stock Exchange)YesCommon StockGBUSDAug 1968
CXXETLX (Eurotlx)YesCommon StockITEURAug 1968
CLX *BMV (Bolsa Mexicana de Valores)YesCommon StockMXMXNAug 1968
CLXBVL (Bolsa de Valores de Lima)YesCommon StockPEUSDAug 1968
CLXC34BOVESPA (Bolsa de Valores de Sao Paulo)BDR EACH REP 0.25 COM USD1.00BRBRLMay 2019

Biography

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The company offers ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/21 05:46
End of Day Share Price2020/09/18 00:00
Earnings2020/06/30
Annual Earnings2020/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.